![Hyo-Jin Shin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hyo-Jin Shin
Directeur Général chez
Medytox Venture Investments
Fortune : 97 973 $ au 31/07/2026
Profil
Hyo-Jin Shin currently works at Medytox Venture Investments, as CEO.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Medy-Tox, Inc.
 Medy-Tox, Inc. BiotechnologyHealth Technology Engages in the research, development, manufacture and sale of biopharmaceutical products 0,03% | 24/08/2026 | 1 940 ( 0,03% ) | 97 973 $ | 31/07/2026 |
Postes actifs de Hyo-Jin Shin
| Sociétés | Poste | Début |
|---|---|---|
Medytox Venture Investments
 Medytox Venture Investments Investment ManagersFinance Medytox Venture invests in companies located in South Korea. The firm targets companies operating in the fields of biotechnology and healthcare services. It provides financing for early stage capital requirements. | Directeur Général | 31/03/2022 |
Formation de Hyo-Jin Shin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Soongsil University
 Soongsil University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medytox Venture Investments
Medytox Venture Investments Investment ManagersFinance Medytox Venture invests in companies located in South Korea. The firm targets companies operating in the fields of biotechnology and healthcare services. It provides financing for early stage capital requirements. | Finance |
